Comparative Veterinary Pharmacology, Toxicology and Therapy

Anaesthesia, Neuroleptanalgesia and Sedation.- 1 Influence of halothane anaesthesia, after xylazine premedication, on serum calcium concentration in the horse.- 2 Pharmacological properties of benzodiazepines in animals.- 3 Effects of halogenated inhalational anaesthetics on respiration in dogs.- 4 Analgesic activity of butorphanol in horses: dosage titration and clinical studies.- Teaching Veterinary Pharmacology.- 5 Postgraduate training in the veterinary pharmacology.- 6 The teaching of veterinary pharmacology and toxicology.- Drug Delivery Systems and Bioavailability.- 7 Design and evaluation of studies on drug delivery systems.- 8 Potential of new drug delivery systems in veterinary medicine.- 9 Influence of injection site on the depot effect of procaine penicillin in dogs.- 10 Influence of food on absorption of antimicrobial drugs.- Smooth Muscle Pharmacology.- 11 Pharmacology of the (fore)-stomach smooth muscles.- 12 Smooth muscle pharmacology of the large intestine.- 13 Recent advances in the pharmacological control of the intestinal and colonic motor profiles.- 14 Cholinergic-like effect of the H2-receptor antagonist ranitidine on the rabbit small intestine.- Comparative Pharmacokinetic Studies.- 15 Comparative pharmacokinetics: introductory remarks.- 16 Comparative neonatal pharmacokinetics.- 17 Comparative pharmacokinetic studies of sulphonamides.- 18 Species differences in protein binding.- Drug Residue Toxicology.- 19 The target animal species in drug toxicity studies: an evaluation of its usefulness and limitations.- 20 The use of pharmacokinetics in chronic toxicity testing.- 21 The Food Animal Residue Avoidance Databank (FARAD): a computer databank of the pharmacokinetics of drugs, pesticides and environmental chemicals in food animals.- Inflammation andAnti-Inflammatory Drugs Immunomodulation.- 22 Modulation of autonomic receptor function by Haemophilus influenzae in the respiratory system.- 23 Impairment of pulmonary homeostatic and antimicrobial defence mechanisms by infectious bovine rhinotracheitis and parainfluenza-3 virus infections.- 24 The potential of biological response modifiers in the treatment of malignancies in animals and man.- 25 Immunological defence mechanisms as a target for antibiotics.- Drug Biotransformation.- 26 Comparative aspects of drug conjugation in laboratory animals, exotic species and man.- 27 Hepatic microsomes as models for comparative metabolism in vivo.- 28 Pharmacokinetics, hydroxylation and acetylation of sulphadimidine in mammals, birds, fish, reptiles and molluscs.- 29 Disposition and metabolism of 14C-mebendazole in sheep and poultry.- Diarrhoea.- 30 Modulation of intestinal ion absorption and secretion by enterotoxins, hormones and neurotransmitters.- 31 Species and age-dependent factors governing the clinical severity of diarrhea.- 32 Antidiarrhoeal therapy.- 33 The effects of veterinary drugs based on humic acids in the treatment of enteritis in young animals.- Clinical Toxicology.- 34 Drug reactions leading to toxicity.- 35 Clinical toxicology of an antibiotic ionophore (monensin) in ponies and horses; diagnostic markers and therapeutic considerations.- 36 Mycotoxins and nnycotoxicoses in Europe.- Pathophysiological Models in Pharmacology, Miscellaneous.- 37 Role of animal disease models in evaluating the efficacy of antimicrobial agents.- 38 Effects of disease states on drug binding to serum proteins.- 39 Tickborne fever: efficacy and effects on pharmacokinetics of some chemotherapeutic agents in the goat.- 40 Statistical methods for evaluation of drug efficacy in animal models.- 41 Pharmacology of carbadox in the pig.- Opiates, Opioids and Neuropeptides.- 42 Opioid peptides and their receptors.- 43 Endorphin systems, pain and addiction.- 44 Opioid effects on gastrointestinal motor and secretory functions.- 45 Central nervous system control of feeding behaviour by some neuropeptides in sheep.- Drug Use and Regulation.- 46 The use in animals of drugs licensed for human use only.- 47 The use in small animal medicine of drugs licensed for human purposes.- 48 The use in animals of drugs licensed for human use: the situation in Sweden.- 49 Regulation of drug usage in veterinary medicine: the situation in Germany.- 50 Do residues of antimicrobial drugs constitute a microbiological risk for the consumer?.